Pressed by lack of time and increasing patient demands, the average American physician is also burdened by a lack of sufficient knowledge concerning mood-altering drugs. This article analyzes the various problems associated with psychoactive drug prescribing and describes how the promotional impact of the pharmaceutical companies has fostered the wide misuse of these drugs.
Get full access to this article
View all access options for this article.
References
1.
American Medical News1973 (July).
2.
New York Times1975 (July 8).
3.
PekkanenJohn1973The American Connection, Chicago: Follett Publishers.
4.
RuckerT. Donald1972“The Role of Computers in Drug Utilization Review.”American Journal of Hospital Pharmacy, 29:128–134.
5.
U.S. Senate, Subcommittee on Monopoly of the Select Committee on Small Business1969Competitive Problems In The Drug Industry (Part 14).
